7-146425696-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.97+308723T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.967 in 152,218 control chromosomes in the GnomAD database, including 71,257 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.97 ( 71257 hom., cov: 30)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.753

Publications

10 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.983 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.97+308723T>C
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.97+308723T>C
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000625365.2
TSL:5
c.97+308723T>C
intron
N/AENSP00000485955.1
CNTNAP2
ENST00000637150.1
TSL:5
n.26+308723T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.967
AC:
147108
AN:
152100
Hom.:
71195
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.991
Gnomad AMI
AF:
0.948
Gnomad AMR
AF:
0.966
Gnomad ASJ
AF:
0.966
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.993
Gnomad FIN
AF:
0.978
Gnomad MID
AF:
0.972
Gnomad NFE
AF:
0.947
Gnomad OTH
AF:
0.967
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.967
AC:
147230
AN:
152218
Hom.:
71257
Cov.:
30
AF XY:
0.969
AC XY:
72142
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.991
AC:
41166
AN:
41532
American (AMR)
AF:
0.966
AC:
14786
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.966
AC:
3355
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5152
AN:
5152
South Asian (SAS)
AF:
0.993
AC:
4790
AN:
4824
European-Finnish (FIN)
AF:
0.978
AC:
10363
AN:
10598
Middle Eastern (MID)
AF:
0.980
AC:
288
AN:
294
European-Non Finnish (NFE)
AF:
0.947
AC:
64423
AN:
68022
Other (OTH)
AF:
0.968
AC:
2044
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
239
478
716
955
1194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.955
Hom.:
30236
Bravo
AF:
0.967
Asia WGS
AF:
0.993
AC:
3454
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
1.4
DANN
Benign
0.52
PhyloP100
-0.75
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1718101; hg19: chr7-146122788; API